Related Experiment Videos

Cryptococcal meningitis: diagnosis and treatment

M A Viviani1

  • 1Istituto di Igiene e Medicina Preventiva, Ospedale Maggiore, Università degli Studi di Milano, Via F. Sforza 35, 20122 Milano, Italy.

International Journal of Antimicrobial Agents
|February 1, 1996
PubMed

Insights

Cryptococcosis incidence is rising due to immunocompromised patients. Itraconazole is a safe and effective treatment option, unlike fluconazole, which raises concerns about resistance.

Area of Science:

  • Medical Mycology
  • Infectious Diseases
  • Immunocompromised Host Research

Background:

  • Rising incidence of cryptococcosis, particularly in immunocompromised individuals like those with AIDS.
  • Cryptococcus neoformans is the primary causative agent of human cryptococcal infections.
  • Pulmonary cryptococcosis is common, while meningitis represents the most severe and often fatal form.

Purpose of the Study:

  • To review the current understanding of cryptococcosis, focusing on diagnosis and treatment.
  • To evaluate the efficacy and safety of various therapeutic options, including azoles.
  • To address concerns regarding antifungal resistance in cryptococcosis management.

Main Methods:

  • Literature review of cryptococcosis incidence, diagnosis, and treatment modalities.
  • Analysis of clinical outcomes associated with different antifungal therapies.
  • Assessment of antifungal resistance patterns, particularly with azole agents.

Main Results:

  • Combined amphotericin B and flucytosine is the initial treatment of choice.
  • Azoles (fluconazole, itraconazole) offer effective alternatives and maintenance therapy, with lower toxicity than amphotericin B.
  • Itraconazole shows promise as maintenance therapy without associated resistance issues, unlike fluconazole.

Conclusions:

  • Effective management of cryptococcosis relies on timely diagnosis and appropriate antifungal therapy.
  • Azole antifungals, especially itraconazole, are valuable for maintenance therapy due to efficacy and safety profiles.
  • Careful consideration of antifungal resistance is crucial, highlighting itraconazole's advantage in this regard.

Related Concept Videos

Cryptococcal Meningitis01:27

Cryptococcal Meningitis

Cryptococcal meningitis is a life-threatening opportunistic infection predominantly associated with HIV/AIDS, accounting for over 100,000 deaths annually worldwide. However, it also affects individuals with other forms of immunosuppression, including those undergoing immunosuppressive therapy, organ transplant recipients, patients with innate immunodeficiencies, and individuals with hematological disorders. The infection is caused mainly by Cryptococcus neoformans and Cryptococcus gattii,...
Viral Meningitis01:18

Viral Meningitis

Viral meningitis is the most common form of meningitis and is often referred to as aseptic meningitis to indicate the absence of bacterial involvement. It is generally milder than bacterial meningitis, with symptoms including fever, headache, stiff neck, drowsiness, nausea, photophobia, and vomiting. Rarely, more severe manifestations or death may occur. Common causative agents include enteroviruses, particularly coxsackie A and B viruses and echoviruses, all members of the Enterovirus genus...
Rocky Mountain Spotted Fever01:26

Rocky Mountain Spotted Fever

Rocky Mountain Spotted Fever (RMSF) is a severe tick-borne illness caused by Rickettsia rickettsii, a Gram-negative, coccobacillary bacterium. This pathogen is an obligate intracellular parasite, requiring a host cell for replication. Transmission occurs through the bite of an infected tick. In the United States, the most important vectors are Dermacentor variabilis (American dog tick) and Dermacentor andersoni (Rocky Mountain wood tick), though other tick species may also serve as vectors.
Brain Abscess l: Introduction01:26

Brain Abscess l: Introduction

A brain abscess is a focal, intracerebral infection characterized by a localized collection of pus within the brain parenchyma, resulting from microbial invasion and the body’s inflammatory response. It progresses through stages: early and late cerebritis, followed by early and late capsule formation, reflecting tissue destruction, immune response, and eventual encapsulation.Etiology and PathogenesisCausative organisms vary with source and host factors, often involving polymicrobial infections,...
Bacterial Meningitis I: Introduction01:22

Bacterial Meningitis I: Introduction

Bacterial meningitis is a severe, life-threatening inflammation of the meninges, particularly the pia mater and arachnoid mater, affecting the subarachnoid space, ventricles, and cerebrospinal fluid (CSF). If untreated, it can lead to significant neurological complications or death.Causative AgentsCommon pathogens vary with age and immune status. In adults, major organisms include Streptococcus pneumoniae, Neisseria meningitidis, and Haemophilus influenzae. Streptococcus agalactiae (group B...
Acute Pyelonephritis II: Diagnostic Studies and Management01:28

Acute Pyelonephritis II: Diagnostic Studies and Management

Introduction:For diagnosing acute pyelonephritis, a comprehensive patient history is collected to identify symptoms such as dysuria, frequent or urgent urination, flank pain, or costovertebral angle (CVA) tenderness that may suggest a kidney infection.Physical ExaminationDuring the physical examination, CVA tenderness is assessed. This involves gentle percussion over the costovertebral angle, where tenderness often indicates a kidney infection.Diagnostic TestsUrinalysis: Used to identify white...